FDA Approved: VALCHLOR — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approves a supplemental application for VALCHLOR (mechlorethamine hydrochloride) to expand its labeling for the topical treatment of cutaneous T-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Valchlor (mechlorethamine)

Snippet

SUPPL AP for VALCHLOR (MECHLORETHAMINE HYDROCHLORIDE)